# Marek Trněný

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/marek-trneny/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,616 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 68 |
| i10-index | 231 |
| Last Known Institution | Karolinska University Hospital |
| OpenAlex ID | https://openalex.org/A5088476247 |
| ORCID iD | https://orcid.org/0000-0002-6952-6073 |
| Works | 760 |

## Researcher papers

- [Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial](https://scholariq.org/papers/addition-of-rituximab-to-fludarabine-and-cyclophosphamide-in-patients-with/)
- [Obinutuzumab for the First-Line Treatment of Follicular Lymphoma](https://scholariq.org/papers/obinutuzumab-for-the-first-line-treatment-of-follicular-lymphoma/)
- [Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis](https://scholariq.org/papers/long-term-outcomes-after-autologous-hematopoietic-stem-cell-transplantation-for/)
- [Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial](https://scholariq.org/papers/prognostic-value-of-end-of-induction-pet-response-after-first-line/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [CNS Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/cns-lymphoma-diagnosis-and-treatment/)
- [Viral-associated cancers and disorders](https://scholariq.org/topics/viral-associated-cancers-and-disorders-2/)

## Researcher university

- [Karolinska University Hospital](https://scholariq.org/institutions/karolinska-university-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.